Integrichain adds more managed services to its commercialization IT business
Acquisition of Cumberland Life Sciences boosts its client base and range of services
The new normal in pharma and clinical trial logistics
Service providers are resetting their business practices to cope with the pandemic
Patient support in the pandemic era
Hub service providers look to telehealth to expand patient connectivity
Navigating the patient journey after rare disease diagnosis
Commercial teams can prepare for overcoming predictable hurdles
For DEA, the opioid-abuse epidemic is being superseded by the Covid-19 pandemic
Production quotas for controlled substances are being raised by 15%
Biotech developmental resources have a new brand: Cytiva
Now a Danaher Corp. asset, the former GE Healthcare Life Sciences business has been reshuffled
The muddled and uncertain future of the chloroquine/hydroxychloroquine ‘cure’ for Covid-19
Newly initiated trials may prove value—but even then, supplies may be limited, and hoarding is already occurring
Evolving Patient Access Programs for Specialty Therapies
When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies
Tips on running virtual meetings
For sessions with co-workers or clients, consider these recommendations
Milken Institute publishes a Covid-19 Tracker to monitor therapy development
As of March 26, 71 treatments and 47 vaccines are in development
Sales growth of pharmaceuticals is slowing globally, says IQVIA annual study
US list-price sales reached $510 billion in 2019
Air cargo stutters, then responds to coronavirus pandemic
Passenger-based carriers are repurposing their flights
Pharma distributors adjust to the Covid-19 pandemic
Healthcare Ready pools industry efforts
DEA weighs in on Covid-19 response
DEA-registered practitioners can prescribe without an in-person interview
DHS national guidance: pharma distribution/logistics staff are ‘critical infrastructure workers’ during Covid-19 crisis
Guidance enables these workers to continue reporting to work
Specialty pharmaceutical patients ‘have difficulty’ obtaining their first dose
CoverMyMeds report gives evidence of ongoing difficulties in patient support
Global site selection comparative costs: India is the global low-cost producer
Copenhagen, Denmark tops Boyd Co.’s list with the highest annual operating costs
ARM assesses pace of cellular, genetic and tissue therapy development
But: the growth number of companies is exceeding the growth of trials
Pharma distribution adjusts to the coronavirus plague
The big question is how well will the system respond to spikes in demand, and lack of product
Hub providers can be the source of the best real-world evidence
A Conversation with Mark Hansan, CareMetx
Pondering the shrinking number of retail pharmacies
PCMA study disputes its members’ harm to brick-and-mortar businesses
2020 Patient Support / Hub Services Report
Dramatic growth tracks the flood of new specialty pharmaceuticals entering the market
Covectra offer low-cost, easy-to-install serialization for small to medium-sized businesses
Level 1-3 serialization with a cloud-based system is up and running in a day
Real-world evidence gets closer to everyday treatment decisions
ICER will expand use of RWE, as the Federal ONC calls for broader use of healthcare data
‘Drugs to Watch’ list tags 11 about-to-be-approved therapies with blockbuster potential
Clarivate Analytics predicts both approvals and commercial potential
IQVIA-Veeva litigation over customer master-data records grinds on
Now two-plus years on, the dispute over physician databases shows no sign of resolution
Eversana takes on a full-scale pharma commercialization
Deal with Evoke Pharmaceuticals anticipates FDA approval
Global CRO market is growing at 7.9% CAGR, says Frost & Sullivan
Europe leads in trial locations
‘Global’ opioid deal is off, says Wall St. Journal
Too many states have opted out of the $18-billion agreement being negotiated in federal court
